Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now OTC Markets OTCPK - Delayed Quote • USD Knight Therapeutics Inc. (KHTRF) Follow Compare 3.9500 0.0000 (0.00%) At close: April 17 at 4:00:00 PM EDT Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for KHTRF 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: KHTRF View More All News Press Releases SEC Filings Knight Therapeutics Inc. ranks on The Globe and Mail’s sixth-annual Women Lead Here benchmark of executive gender diversity TSX Growth Stocks With Up To 86% Insider Driven Earnings Expansion Knight Therapeutics Full Year 2024 Earnings: Beats Expectations Knight Therapeutics Announces Launch of Minjuvi® (tafasitamab) in Mexico Knight Therapeutics Inc (KHTRF) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amidst ... Knight Therapeutics Reports Fourth Quarter and Year-End 2024 Results Notice of Knight Therapeutics' Fourth Quarter and Year End 2024 Results Conference Call Knight Therapeutics Price Target Raised at RBC, Raymond James Knight Therapeutics to Acquire Paladin TSX Growth Companies With High Insider Ownership In February 2025 Knight Therapeutics and Helsinn Healthcare SA Expand Relationship and Enter into Exclusive License, Distribution, and Supply Agreement for Onicit®